Skip to main content
Erschienen in: Esophagus 3/2017

23.12.2016 | Case Report

Barrett’s Esophageal Adenocarcinoma with CREST Syndrome

verfasst von: Tomohiro Kunishige, Sohei Matsumoto, Kohei Wakatsuki, Kazuhiro Migita, Masahiro Ito, Hiroshi Nakade, Mitsuhiro Nakatani, Mutsuko Kitano, Kohei Morita, Chiho Obayashi, Yoshiyuki Nakajima

Erschienen in: Esophagus | Ausgabe 3/2017

Einloggen, um Zugang zu erhalten

Abstract

Scleroderma is a systemic and connective tissue disease. Gastrointestinal manifestations including esophageal dysmotility are common in scleroderma patients. The relationship between esophageal reflux and scleroderma has been well described; however, the complication of Barrett’s esophagus and adenocarcinoma due to chronic esophagitis is rare. In addition, there are no detailed reports on the treatment of esophageal adenocarcinoma or the pathological findings in patients with scleroderma. We report the case of a 55-year-old woman who presented with chronic cough and a dilated esophagus. The patient was diagnosed with Barrett’s adenocarcinoma and CREST syndrome, which is a form of scleroderma. Subtotal esophagectomy was performed, and the patient’s chronic cough was relieved. A surgical specimen revealed histological changes at the dilated parts of the esophagus that showed the thinning of the muscular layer with fibrotic changes.
Literatur
1.
Zurück zum Zitat Winterbauer RH. Multiple Telangiectasia, Raynaud’s Phenomenon, Sclerodactyly, and Subcutanious Calcinosis: A Syndrome Mimicking Hereditary Hemorrhagic Telangiectasia. Bull Johns Hopkins Hosp. 1964;114:361–83.PubMed Winterbauer RH. Multiple Telangiectasia, Raynaud’s Phenomenon, Sclerodactyly, and Subcutanious Calcinosis: A Syndrome Mimicking Hereditary Hemorrhagic Telangiectasia. Bull Johns Hopkins Hosp. 1964;114:361–83.PubMed
2.
Zurück zum Zitat Salerni R, Rodnan GP, Leon DF, et al. Pulmonary hypertension in the CREST syndrome variant of progressive systemic sclerosis (scleroderma). Ann Intern Med. 1977;86:394–9.CrossRefPubMed Salerni R, Rodnan GP, Leon DF, et al. Pulmonary hypertension in the CREST syndrome variant of progressive systemic sclerosis (scleroderma). Ann Intern Med. 1977;86:394–9.CrossRefPubMed
3.
Zurück zum Zitat McKinley M, Sherlock P. Barrett’s esophagus with adenocarcinoma in scleroderma. Am J Gastroenterol. 1984;79:438–9.PubMed McKinley M, Sherlock P. Barrett’s esophagus with adenocarcinoma in scleroderma. Am J Gastroenterol. 1984;79:438–9.PubMed
4.
Zurück zum Zitat Akiyama Y, Tanaka M, Takeishi M, et al. Clinical, serological and genetic study in patients with CREST syndrome. Intern Med. 2000;39:451–6.CrossRefPubMed Akiyama Y, Tanaka M, Takeishi M, et al. Clinical, serological and genetic study in patients with CREST syndrome. Intern Med. 2000;39:451–6.CrossRefPubMed
5.
Zurück zum Zitat Wipff J, Allanore Y, Soussi F, et al. Prevalence of Barrett’s esophagus in systemic sclerosis. Arthritis Rheum. 2005;52:2882–8.CrossRefPubMed Wipff J, Allanore Y, Soussi F, et al. Prevalence of Barrett’s esophagus in systemic sclerosis. Arthritis Rheum. 2005;52:2882–8.CrossRefPubMed
6.
Zurück zum Zitat Sharma P, McQuaid K, Dent J, et al. A critical review of the diagnosis and management of Barrett’s esophagus: the AGA Chicago Workshop. Gastroenterology. 2004;127:310–30.CrossRefPubMed Sharma P, McQuaid K, Dent J, et al. A critical review of the diagnosis and management of Barrett’s esophagus: the AGA Chicago Workshop. Gastroenterology. 2004;127:310–30.CrossRefPubMed
7.
Zurück zum Zitat Wipff J, Coriat R, Masciocchi M, et al. Outcomes of Barrett’s oesophagus related to systemic sclerosis: a 3-year EULAR Scleroderma Trials and Research prospective follow-up study. Rheumatology (Oxford). 2011;50:1440–4.CrossRefPubMed Wipff J, Coriat R, Masciocchi M, et al. Outcomes of Barrett’s oesophagus related to systemic sclerosis: a 3-year EULAR Scleroderma Trials and Research prospective follow-up study. Rheumatology (Oxford). 2011;50:1440–4.CrossRefPubMed
8.
Zurück zum Zitat Hashimoto A, Arinuma Y, Nagai T, et al. Incidence and the risk factor of malignancy in Japanese patients with systemic sclerosis. Intern Med. 2012;51:1683–8.CrossRefPubMed Hashimoto A, Arinuma Y, Nagai T, et al. Incidence and the risk factor of malignancy in Japanese patients with systemic sclerosis. Intern Med. 2012;51:1683–8.CrossRefPubMed
9.
Zurück zum Zitat Maekawa Y, Nogami R. A case of progressive systemic sclerosis associated with sarcoidosis and esophageal adenocarcinoma. J Dermatol. 1993;20:45–8.CrossRefPubMed Maekawa Y, Nogami R. A case of progressive systemic sclerosis associated with sarcoidosis and esophageal adenocarcinoma. J Dermatol. 1993;20:45–8.CrossRefPubMed
10.
Zurück zum Zitat Halpert RD, Laufer I, Thompson JJ, et al. Adenocarcinoma of the esophagus in patients with scleroderma. AJR Am J Roentgenol. 1983;140:927–30.CrossRefPubMed Halpert RD, Laufer I, Thompson JJ, et al. Adenocarcinoma of the esophagus in patients with scleroderma. AJR Am J Roentgenol. 1983;140:927–30.CrossRefPubMed
11.
Zurück zum Zitat Segel MC, Campbell WL, Medsger TA Jr, et al. Systemic sclerosis (scleroderma) and esophageal adenocarcinoma: Is increased patient screening necessary? Gastroenterology. 1985;89:485–8.CrossRefPubMed Segel MC, Campbell WL, Medsger TA Jr, et al. Systemic sclerosis (scleroderma) and esophageal adenocarcinoma: Is increased patient screening necessary? Gastroenterology. 1985;89:485–8.CrossRefPubMed
12.
Zurück zum Zitat Katzka DA, Reynolds JC, Saul SH, et al. Barrett’s metaplasia and adenocarcinoma of the esophagus in scleroderma. Am J Med. 1987;82:46–52.CrossRefPubMed Katzka DA, Reynolds JC, Saul SH, et al. Barrett’s metaplasia and adenocarcinoma of the esophagus in scleroderma. Am J Med. 1987;82:46–52.CrossRefPubMed
13.
Zurück zum Zitat Niv Y, Abu-Avid S, Yelin A, et al. Barrett’s epithelium and esophageal adenocarcinoma in scleroderma. Am J Gastroenterol. 1988;83:792–3.PubMed Niv Y, Abu-Avid S, Yelin A, et al. Barrett’s epithelium and esophageal adenocarcinoma in scleroderma. Am J Gastroenterol. 1988;83:792–3.PubMed
14.
Zurück zum Zitat Recht MP, Levine MS, Katzka DA, et al. Barrett’s esophagus in scleroderma: increased prevalence and radiographic findings. Gastrointest Radiol. 1988;13:1–5.CrossRefPubMed Recht MP, Levine MS, Katzka DA, et al. Barrett’s esophagus in scleroderma: increased prevalence and radiographic findings. Gastrointest Radiol. 1988;13:1–5.CrossRefPubMed
15.
Zurück zum Zitat Ilan Y, Shouval D, Galun E, et al. Esophageal malignancy after liver transplantation in a patient with Barrett’s esophagus. Scand J Gastroenterol. 1996;31:415–6.CrossRefPubMed Ilan Y, Shouval D, Galun E, et al. Esophageal malignancy after liver transplantation in a patient with Barrett’s esophagus. Scand J Gastroenterol. 1996;31:415–6.CrossRefPubMed
16.
Zurück zum Zitat Medsger TA Jr, Masi AT, Rodnan GP, et al. Survival with systemic sclerosis (scleroderma). A life-table analysis of clinical and demographic factors in 309 patients. Ann Intern Med. 1971;75:369–76.CrossRefPubMed Medsger TA Jr, Masi AT, Rodnan GP, et al. Survival with systemic sclerosis (scleroderma). A life-table analysis of clinical and demographic factors in 309 patients. Ann Intern Med. 1971;75:369–76.CrossRefPubMed
Metadaten
Titel
Barrett’s Esophageal Adenocarcinoma with CREST Syndrome
verfasst von
Tomohiro Kunishige
Sohei Matsumoto
Kohei Wakatsuki
Kazuhiro Migita
Masahiro Ito
Hiroshi Nakade
Mitsuhiro Nakatani
Mutsuko Kitano
Kohei Morita
Chiho Obayashi
Yoshiyuki Nakajima
Publikationsdatum
23.12.2016
Verlag
Springer Japan
Erschienen in
Esophagus / Ausgabe 3/2017
Print ISSN: 1612-9059
Elektronische ISSN: 1612-9067
DOI
https://doi.org/10.1007/s10388-016-0566-0

Weitere Artikel der Ausgabe 3/2017

Esophagus 3/2017 Zur Ausgabe

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.